SCHEMBL22044129

SCHEMBL22044129

O=C(Nc1ccccc1)c1ccc(-c2c[nH]c3ncccc23)s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.66
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
PPARG P37231 2/20 0.53
NCOA2 Q15596 1/20 0.53
NCOA1 Q15788 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53
KDM4E B2RXH2 2/20 0.50
NR2E3 Q9Y5X4 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
ESRRG P62508 2/20 0.49
PTPN1 P18031 1/20 0.49
PTPN11 Q06124 1/20 0.49
ROCK1 Q13464 2/20 0.48
CYP3A4 P08684 1/20 0.48
CAMKK2 Q96RR4 2/20 0.48
CCNB2 O95067 1/20 0.48
CDK1 P06493 1/20 0.48
CCNB1 P14635 1/20 0.48
CCNB3 Q8WWL7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4479178 0.85 AKT1 (0.64) AKT1KDM4EROCK1CYP3A4CAMKK2
SCHEMBL13887780 0.84 AKT1 (0.67) AKT1ESRRGROCK1CYP3A4CAMKK2
SCHEMBL22044015 0.83 NPC1 (0.58) AKT1NPC1RAB9APPARGNCOA2
SCHEMBL4376699 0.82 AKT1 (0.63) AKT1ROCK1CYP3A4CAMKK2MAP3K5
SCHEMBL13887791 0.81 AKT1 (0.63) AKT1NPC1RAB9AROCK1CYP3A4
SCHEMBL4583609 0.80 AKT1 (1.00) AKT1ROCK1CDK1MAP3K5JAK3
SCHEMBL22044904 0.80 DYRK1A (0.51) AKT1RAB9AROCK1CYP3A4CAMKK2
SCHEMBL22044055 0.79 NPC1 (0.53) AKT1NPC1RAB9APPARGNCOA2
SCHEMBL4584324 0.78 AKT1 (0.85) AKT1ROCK1CDK1MAP3K5JAK3
SCHEMBL13887692 0.78 AKT1 (0.59) AKT1ROCK1CYP3A4CAMKK2CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172521-A1 Five-Membered-Fused-Six-Membered Aza-Aromatic Ring Compound, Preparation Method Thereof, Pharmaceutical Composition And Application Thereof Amcure Biosciences Pte. Ltd. (SG) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172521-A1 Five-Membered-Fused-Six-Membered Aza-Aromatic Ring Compound, Preparation Method Thereof, Pharmaceutical Composition And Application Thereof KRAS, NRAS, RASSF5 AKT1 384/4885NPC1 2933/4885RAB9A 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.